Related Experiment Video

Updated: Jan 22, 2026

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
10:29

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

Published on: November 12, 2010

40.5K

Polatuzumab Vedotin Approved for DLBCL

    Cancer Discovery
    |June 28, 2019
    PubMed

    Abstract:

    The antibody-drug conjugate polatuzumab vedotin has been approved to treat relapsed or refractory diffuse large B-cell lymphoma. The drug recognizes the CD79b protein on B cells and kills them with a molecule that prevents tubulin polymerization.

    More Related Videos

    Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
    10:03

    Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

    Published on: August 1, 2013

    17.5K
    Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
    08:56

    Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

    Published on: July 12, 2022

    3.5K

    Related Experiment Videos

    Last Updated: Jan 22, 2026

    The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
    10:29

    The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression

    Published on: November 12, 2010

    40.5K
    Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
    10:03

    Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

    Published on: August 1, 2013

    17.5K
    Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
    08:56

    Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

    Published on: July 12, 2022

    3.5K

    Related Concept Videos

    FDA Approved Drugs: Changes to Approved Drugs01:26

    FDA Approved Drugs: Changes to Approved Drugs

    247
    Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
    247
    Obedience01:08

    Obedience

    35.2K
    According to obedience research, we may harm others under the forceful pressures of an authority figure (Milgram, 1974). How about if the inappropriate orders were delivered with less force? The increasing interdependence between nurses and physicians compelled Hofling and his colleagues to explore nurses’ reactions to a potentially harmful medical request made by the perceived authority figure, the doctor (Hofling, Brotzman, Dalrymple, Graves, & Pierce, 1966). In this situation,...
    35.2K
    Ethics in Research01:56

    Ethics in Research

    25.4K
    Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
    25.4K

    Articles linked to this work by shared authors, journal, and citation graph.

    Q&A: Eileen O'Reilly on Pancreatic Cancer.

    Cancer discovery·2026

    Cellular and molecular mechanisms determining allogeneic CAR T cell rejection and expansion.

    Cancer discovery·2026

    Microplastics and Cancer: Still Searching for Causation.

    Cancer discovery·2026

    Targeting RAS for Pancreatic Cancer Interception.

    Cancer discovery·2026

    The liver niche accelerates, while the lung niche restrains secondary spread of breast cancer.

    Cancer discovery·2026

    Dual Functions of B7-H3-MAPK Signaling Orchestrate Tumor Immunosuppression via Regulating the Plasticity of Myeloid-derived Suppressor Cells and Fibroblasts.

    Cancer discovery·2026

    A Markov model cost threshold analysis of potential hepatitis B virus cure regimens.

    Clinical and translational gastroenterology·2026

    Efficacy and safety of radiofrequency hyperthermia combined with immune checkpoint inhibitors and chemotherapy as first-line treatment for HER2-negative advanced gastric/gastroesophageal junction adenocarcinoma: A propensity score-matched study.

    Human vaccines & immunotherapeutics·2026

    Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2026

    Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease.

    Oncoimmunology·2026

    Is there a role for palliative care in CAR T-cell therapy?

    Current opinion in supportive and palliative care·2026

    Synergistic Antitumor Effects and Reduced Systemic Toxicity of Berberine Chloride Combined With Cisplatin in a Female BALB/c Mouse Xenograft Model.

    Cell biology international·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us